The brittleness of aging bones -- more than a loss of bone mass
August 29, 2011 by Lynn Yarris in Medical research
At each size scale, the hierarchical structure of human cortical bone influences its susceptibility to fracturing with smaller levels affecting intrinsic toughness and higher levels impacting extrinsic toughness. Image courtesy of Ritchie, et. al
It is a well-established fact that as we grow older, our bones become more brittle and prone to fracturing. It is also well established that loss of mass is a major reason for older bones fracturing more readily than younger bones, hence medical treatments have focused on slowing down this loss. However, new research from scientists at the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) shows that at microscopic dimensions, the age-related loss of bone quality can be every bit as important as the loss of quantity in the susceptibility of bone to fracturing.
Using a combination of x-ray and electron based analytical techniques as well as macroscopic fracture testing, the researchers showed that the advancement of age ushers in a degradation of the mechanical properties of human cortical bone over a range of different size scales. As a result, the bone's ability to resist fracture becomes increasingly compromised. This age-related loss of bone quality is independent of age-related bone mass loss.
"In characterizing age-related structural changes in human cortical bone at the micrometer and sub micrometer scales, we found that these changes degrade both the intrinsic and extrinsic toughness of bone," says Berkeley Lab materials scientist Robert Ritchie. "Based on multiscale structural and mechanical tests, we attribute this degradation to a hierarchical series of coupled mechanisms that start at the molecular level."
Ritchie, who holds joint appointments with Berkeley Lab's Materials Sciences Division and the University of California (UC) Berkeley's Materials Science and Engineering Department, is the senior author of a paper published in the Proceedings of the National Academy of Science (PNAS) that describes this work. The paper is titled "Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales."
Co-authoring the PNAS paper with Ritchie were Elizabeth Zimmermann, Eric Schaible, Hrishikesh Bale, Holly Barth, Simon Tang, Peter Reichert, Björn Busse, Tamara Alliston and Joel Ager.
These graphs show the mechanical properties of human cortical bone as a function of age for (A) strength and (B) fracture-toughness. Image courtesy of Ritchie, et. al
Human cortical or compact bone is a composite of collagen molecules and nanocrystals of a mineralized form of calcium called hydroxyapatite (HA). Mechanical properties of stiffness, strength and toughness arise from both the characteristic structure at the nanoscale, and at multiple length scales through the hierarchical architecture of the bone. These length scales extend from the molecular level to the osteonal structures at near-millimeter levels. An osteon is the basic structural unit of compact bone, comprised of a central canal surrounded by concentric rings of lamellae plates, through which bone remodels.
"Mechanisms that strengthen and toughen bone can be identified at most of these structural length scales and can be usefully classified, as in many materials, in terms of
intrinsic toughening mechanisms at small length scales, promoting non-brittle behavior, and extrinsic toughening mechanisms at larger length scales acting to limit the growth of cracks," Ritchie says. "These features are present in healthy, young human bone and are responsible for its unique mechanical properties. However, with biological aging, the ability of these mechanisms to resist fracture deteriorates leading to a reduction in bone strength and fracture toughness."
Working with the exceptionally bright beams of x-rays at Berkeley Lab's Advanced Light Source (ALS), Ritchie and his colleagues analyzed bone samples that ranged in age between 34 and 99 years. In situ small-angle x-ray scattering and wide-angle x-ray diffraction were used to characterize the mechanical response of the collagen and mineral at the sub micrometer level. A combination of x-ray computed tomography and in situ fracture-toughness measurements with a scanning electron microscope were used to characterize effects at micrometer levels.
"We found that biological aging increases non-enzymatic cross-linking between the collagen molecules, which suppresses plasticity at nanoscale dimensions, meaning that collagen fibrils can no longer slide with respect to one another as a way to absorb energy from an impact," Ritchie says. "We also found that biological aging increases osteonal density, which limits the potency of crack-bridging mechanisms at micrometer scales."
These two mechanisms that act to reduce bone toughness are coupled, Ritchie says, in that the increased stiffness of the cross-linked collagen requires energy to be absorbed by "plastic" deformation at higher structural levels, which occurs by the process of micro cracking.
"With age, remodeling of the bone can lead the osteons to triple in number, which means the channels become more closely packed and less effective at deflecting the growth of cracks," he says. "This growing ineffectiveness must be accommodated at higher structural levels by increased micro cracking. In turn, the increased micro cracking compromises the formation of crack bridges, which provide one of the main sources of extrinsic toughening in bone at length scales in the range of tens to hundreds of micrometers. Thus, age-related changes occur across many levels of the structure to increase the risk of fracture with age."
Provided by
Lawrence Berkeley National Laboratory
-
MIT probes secret to bone's strength
Aug 27, 2007 |
not rated yet |
0
-
Scientists probe secret of bone's strength
Sep 07, 2007 |
not rated yet |
0
-
Bones at the nanoscale
Nov 07, 2006 |
not rated yet |
0
-
A little magic provides an atomic-level look at bone
Dec 02, 2009 |
not rated yet |
0
-
Proteins to yield new clues in fight against osteoporosis
Sep 29, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
10 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Implantable pain disk may help those with cancer
An estimated 3.5 million cancer patients around the globe are in severe pain from their disease, but many get no relief.
Medical research
8 hours ago |
not rated yet |
0
|
Energy levels link sleep control mechanisms
Sleep, or lack of it, can determine level of cognitive performance which is linked with accidents as well as increased risk of serious health problems. Links between cell energy levels, gene transcription ...
Medical research
10 hours ago |
not rated yet |
0
Researchers identify key brain cell in antidepressant action
(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.
Medical research
10 hours ago |
not rated yet |
0
|
Rockefeller scientists pioneer new method to determine mechanisms of drug action
(Medical Xpress) -- Knowing that a drug works is great. Knowing how it works is a luxury. And until now, determining a drugs mechanism of action has been a tedious and difficult process for scientists.
Medical research
10 hours ago |
not rated yet |
0
|
Like curry? New biological role identified for compound used in ancient medicine
Scientists have just identified a new reason why some curry dishes, made with spices humans have used for thousands of years, might be good for you.
Medical research
18 hours ago |
4.3 / 5 (7) |
1
|
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
